Gene · 5313
Papers2,223
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
601 to 620 of 2,223
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Glycolysis Rate-Limiting Enzymes: Novel Potential Regulators of Rheumatoid Arthritis Pathogenesis. | Front Immunol | 2021 | 34899740 | PubTator, text mining | PubMed |
| The Crosstalk Between Signaling Pathways and Cancer Metabolism in Colorectal Cancer. | Front Pharmacol | 2021 | 34887764 | PubTator, text mining | PubMed |
| miR1908-5p regulates energy homeostasis in hepatocyte models. | Sci Rep | 2021 | 34887471 | PubTator, text mining | PubMed |
| Mechanism of Hip Arthropathy in Ankylosing Spondylitis: Abnormal Myeloperoxidase and Phagosome. | Front Immunol | 2021 | 34880852 | PubTator, text mining | PubMed |
| Interleukin -1β Promotes Lung Adenocarcinoma Growth and Invasion Through Promoting Glycolysis via p38 Pathway. | J Inflamm Res | 2021 | 34880649 | PubTator, text mining | PubMed |
| Combined Analysis of Expression Profiles in a Mouse Model and Patients Identified BHMT2 as a New Regulator of Lipid Metabolism in Metabolic-Associated Fatty Liver Disease. | Front Cell Dev Biol | 2021 | 34869329 | PubTator, text mining | PubMed |
| Hyperlipidemia May Synergize with Hypomethylation in Establishing Trained Immunity and Promoting Inflammation in NASH and NAFLD. | J Immunol Res | 2021 | 34859106 | PubTator, text mining | PubMed |
| Induced Pluripotent Stem Cells as a Tool for Modeling Hematologic Disorders and as a Potential Source for Cell-Based Therapies. | Cells | 2021 | 34831472 | PubTator, text mining | PubMed |
| Dynamic Variations of 3'UTR Length Reprogram the mRNA Regulatory Landscape. | Biomedicines | 2021 | 34829789 | PubTator, text mining | PubMed |
Long-read single molecule real-time (SMRT) sequencing of GBA1 locus in Gaucher disease national cohort from Argentina reveals high frequency of complex allele underlying severe skeletal phenotypes: Collaborative study from the Argentine Group for Diagnosis and Treatment of Gaucher Disease. | Mol Genet Metab Rep | 2021 | 34820281 | PubTator, text mining | PubMed |
| MYC break-apart FISH probe set reveals frequent unbalanced patterns of uncertain significance when evaluating aggressive B-cell lymphoma. | Blood Cancer J | 2021 | 34819491 | PubTator, text mining | PubMed |
An open-label, randomized, single intravenous dosing study to investigate the effect of fixed-dose combinations of tenofovir/lamivudine or atazanavir/ritonavir on the pharmacokinetics of remdesivir in Ugandan healthy volunteers (RemTLAR). | Trials | 2021 | 34814933 | PubTator, text mining | PubMed |
| PKM2 Is a Potential Diagnostic and Therapeutic Target for Retinitis Pigmentosa. | Dis Markers | 2021 | 34804260 | PubTator, text mining | PubMed |
| Generation and Export of Red Blood Cell ATP in Health and Disease. | Front Physiol | 2021 | 34803737 | PubTator, text mining | PubMed |
| CircTP63 promotes cell proliferation and invasion by regulating EZH2 via sponging miR-217 in gallbladder cancer. | Cancer Cell Int | 2021 | 34789260 | PubTator, text mining | PubMed |
| The 5' and 3' Untranslated Regions of the Japanese Encephalitis Virus (JEV): Molecular Genetics and Higher Order Structures. | Front Microbiol | 2021 | 34777278 | PubTator, text mining | PubMed |
| Introns encode dsRNAs undetected by RIG-I/MDA5/interferons and sensed via RNase L. | Proc Natl Acad Sci U S A | 2021 | 34772806 | PubTator, text mining | PubMed |
| The Key Role of the WNT/β-Catenin Pathway in Metabolic Reprogramming in Cancers under Normoxic Conditions. | Cancers (Basel) | 2021 | 34771718 | PubTator, text mining | PubMed |
| A Protocol for Preconceptional Screening of Consanguineous Couples Using Whole Exome Sequencing. | Front Genet | 2021 | 34759951 | PubTator, text mining | PubMed |
| Role of PKM2-Mediated Immunometabolic Reprogramming on Development of Cytokine Storm. | Front Immunol | 2021 | 34759927 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5313/papers?page=31